IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bios Capital Management, LP

Q1 2026 Holdings

Filed 2026-05-13 | 10 holdings | $52.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Actuate Therapeutics Inc(ACTU)COM005083100$27.5M10,049,99652.1%
Opus Genetics Inc(IRD)COM67577R102$16.8M3,683,42931.7%
Cognition Therapeutics Inc(CGTX)COM19243B102$4.6M6,000,0008.6%
Rein Therapeutics Inc(RNTX)COM NEW00887A204$2.6M1,982,3754.9%
Lantern Pharma Inc(LTRN)COM51654W101$1.2M864,4352.2%
In8bio Inc(INAB)COM NEW45674E208$248.4K167,8050.5%